Economics ❯Healthcare Economics
Clinical Trials Drug Pricing Drug Approval Health Equity HIV/AIDS FDA Approval Infectious Diseases Cost Analysis
Generic manufacturers are set to produce lenacapavir for as little as $25 per patient annually
